REG - Alkemy Capital Invs. - Exercise of Warrants and Loan Conversion

Alkemy Capital InvestmentsAnnouncement

27/11/2025 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251127:nRSa3332Ja&default-theme=true

RNS Number : 3332J  Alkemy Capital Investments PLC  27 November 2025

27 November 2025

 

Alkemy Capital Investments Plc

Exercise of Warrants and Loan Conversion

 

Alkemy Capital Investments Plc ("Alkemy" or the "Company") (LSE: ALK)
(JV2:FRA) has received notice to exercise the following warrants:

·    18,320 broker warrants of £1.00 each, which were issued as per the
RNS dated 18 December 2023, resulting in the receipt of £18,320;

·    166,000 investor warrants of £2.00 each and 50,000 broker warrants
of £1.25 each, which were issued as per the RNS dated 17 February 2025,
resulting in the receipt of a further £394,500;

·    253,333 investor warrants of £2.25 each and 25,333 broker warrants
of £1.50 each, which were issued as per the RNS dated 25 June 2025, resulting
in the receipt of a further £607,999.

Accordingly a total of £1,020,819 has been received from warrant exercises
which will help fund working capital as the Company completes its FEED study
which is now well advanced.

The Company has also received a loan conversion notice from the debt facility
provider, as set out in the RNS dated 31 July 2025, pursuant to which
£250,000 of principal and £4,932 of interest is being converted at £2.77,
resulting in the issue of 92,169 ordinary shares of 2 pence each in the
Company ("Ordinary Shares").

The Company will accordingly issue 605,155 new Ordinary Shares in the Company
(the "New Ordinary Shares") and following the completion of these warrant
exercises and the loan conversion the Company will have 10,572,020 Ordinary
Shares in issue.

Chairman of Alkemy, Paul Atherley, commented:

 

"We very much welcome the overwhelming support the Company has had from its
warrant holders with the majority of outstanding warrants available for
conversion having been converted, providing the company with over £1 million
in working capital to complete the FEED study ahead of the main finance, which
is anticipated to occur in the first quarter of the new year.

 

The FEED study is progressing well with a strong focus on reducing the already
low capital and operating costs making Tees Valley Lithium internationally
highly competitive.

 

Tees Valley Lithium has engaged ABG Sundal Collier to arrange the asset level
finance and the low capital cost and strong operating margins, we believe, are
making the project highly attractive to debt and equity markets. The aim is to
be in a position to draw down finance and commencement construction in the
first quarter of the new year.

 

We were pleased with the reference by Industry Minister Chris McDonald who,
referring to TVL, told Reuters that a London-based company planning a lithium
refinery in Teesside, northern England to supply battery-grade materials for
electric vehicles, was "very, very close to the final stage" and predicted
"spades in the ground"."

 

Admission

Application will be made for the New Ordinary Shares to be admitted to trading
on the Equity Shares (transition) category of the Official List and the Main
Market of the London Stock Exchange at 8.00 a.m. on 3 December 2025
("Admission").

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's
Disclosure Guidance and Transparency Rules, that on Admission, the Company's
enlarged share capital will consist of 10,572,020 Ordinary Shares. This figure
may be used by shareholders as the denominator for the calculations by which
they will determine if they are required to notify their interest in, or a
change to their interest in, the Company under the FCA's Disclosure Guidance
and Transparency Rules.

 

Further information

 

For further information, please visit Alkemy's
website: www.alkemycapital.co.uk (http://www.alkemycapital.co.uk/)  or TVL's
website www.teesvalleylithium.co.uk (http://www.teesvalleylithium.co.uk/) .

-Ends-

 Alkemy Capital Investments Plc  Tel: 0207 317 0636

                                 info@alkemycapital.co.uk (mailto:info@alkemycapital.co.uk)
 Zeus Capital                    Tel: 0203 829 5000

 

ABOUT US

 

Alkemy Capital Investments plc: Alkemy is focused on the development of
critical mineral infrastructure to support the global energy transition.
Through its wholly owned subsidiary, TVL, Alkemy is leading the way in
establishing Europe's first independent lithium hydroxide refinery.

 

Tees Valley Lithium Limited: TVL is committed to supplying battery-grade
lithium chemicals to meet the growing demand of the electric vehicle supply
chain in Europe. Strategically located at in Teesside, UK, TVL is developing a
low-carbon, independent lithium supply chain for European battery
manufacturers.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBRBITMTJTBFA



            Copyright 2019 Regulatory News Service, all rights reserved